MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark
July 27, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results
July 19, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, July 19, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine
May 17, 2023 08:00 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, May 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG
May 09, 2023 08:15 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, May 09, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences to Participate at the Inaugural EF Hutton Global Conference
May 08, 2023 08:15 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, May 08, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference
May 02, 2023 08:15 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, May 02, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a next-generation, AI ECG medical...
HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023
April 17, 2023 08:15 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, April 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused...
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results
March 16, 2023 16:15 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, March 16, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused...
HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time
February 07, 2023 11:04 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused...
HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease
February 06, 2023 07:30 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused...